• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Rosas, C.
    Rattay, T.
    Azria, D.
    Elliott, Rebecca M
    Gutierrez-Enriquez, S.
    Rancati, T.
    Rosenstein, B. S.
    De Ruysscher, D.
    Sperk, E.
    Stobart, H.
    Symonds, R. P.
    Talbot, C. J.
    De Santis, M. C.
    Vega, A.
    Veldeman, L.
    Webb, A.
    West, Catharine M L
    Chang-Claude, J.
    Seibold, P.
    Show allShow less
    Affiliation
    German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg , Germany
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective The aims of this study were to assess fatigue levels over time in breast cancer patients receiving radiotherapy (RT), and to identify demographic and treatment factors associated with multiple dimensions of long-term fatigue. Materials and Methods Data from breast cancer patients undergoing adjuvant RT after breast-conserving surgery was collected in a prospective international multicentre cohort study (www.requite.eu), including treatment/disease factors, baseline sociodemographic data and patient-reported outcomes. 31% of patients also received chemotherapy. Fatigue was measured at four time points (pre-RT, end of RT, 12 months and 24 months after RT) using the Multidimensional Fatigue Inventory (MFI-20) to assess general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation. The prevalence of moderate-severe fatigue was calculated using a cut-point of >12 (scale range 4-20). The change in fatigue levels over time was analyzed using Friedman test followed by pairwise Wilcoxon signed-rank test. Multivariable logistic regression models (including chemotherapy) were used to identify factors associated with the occurrence of fatigue two years after RT for every MFI-20 dimension. Results A total of 1443, 1302, and 1098 patients completed the MFI-20 at baseline, end of RT and two years after RT. The prevalence of moderate-severe general fatigue in our sample was 37%, 50%, and 34%, respectively. Patients with chemotherapy had higher baseline fatigue levels (Fig. 1). From baseline to the end of RT, levels of fatigue significantly increased for all MFI 20 dimensions (p-values <0.05). Fatigue levels had their peak at the end of RT and returned to baseline levels after two years for mental fatigue. For the other four MFI-20 dimensions, there was a statistically significant decrease in fatigue levels when comparing the baseline and two-year measurements (p-values <0.05). Baseline fatigue, depression, sleeping disorders, and dyspnea were significantly associated with the occurrence of general fatigue 2 years after RT (e.g., depression OR = 1.75, 95% CI 1.04-2.92), whereas overall quality of life was inversely associated (OR = 0.85, 95% CI 0.77- 0.94). In addition to the previously mentioned variables, other factors such as obesity or pain were associated with other fatigue domains. Conclusion Fatigue is a prevalent symptom in long-term breast cancer survivors receiving RT. Fatigue levels peaked by the end of RT and declined to baseline levels afterwards. Despite this overall decline, still a third of patients reported moderate-severe fatigue two years after RT. Several patient demographic factors and quality of life at baseline were associated with different dimensions of long-term fatigue. Screening for fatigue should be implemented in routine care to identify patients at a higher risk of developing long-term fatigue so that tailored interventions (e.g., psychological, exercise) can be offered in early phases.
    Citation
    Rosas C, Rattay T, Azria D, Elliott RM, Gutierrez-Enriquez S, Rancati T, et al. Determinants of fatigue and longitudinal changes up to 2 years post-radiotherapy for breast cancer. Radiotherapy and Oncology. 2022 May;170:S723-S4. PubMed PMID: WOS:000806764200351.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/625517
    Type
    Meetings and Proceedings
    Collections
    All Paterson Institute for Cancer Research

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.